<?xml version="1.0" encoding="UTF-8"?>
<ref id="B92-pharmaceuticals-12-00147">
 <label>92.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Deeg</surname>
    <given-names>C.M.</given-names>
   </name>
   <name>
    <surname>Hassan</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Mutz</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Rheinemann</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Götz</surname>
    <given-names>V.</given-names>
   </name>
   <name>
    <surname>Magar</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Schilling</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Kallfass</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Nürnberger</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Soubies</surname>
    <given-names>S.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>In vivo evasion of MxA by avian influenza viruses requires human signature in the viral nucleoprotein</article-title>
  <source>J. Exp. Med.</source>
  <year>2017</year>
  <pub-id pub-id-type="doi">10.1084/jem.20161033</pub-id>
 </element-citation>
</ref>
